|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Mon 5/6
|
|
Download |
|
|
|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
N/A |
Shares
Out: |
239,210,000 |
Market
Cap: |
478.42(K) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.000001 - $1.3 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Amyris is a biotechnology company. Co. creates, manufactures and commercializes consumer products and ingredients. Co.'s ingredients and consumer products are powered by its fermentation-based Lab-to-Market technology platform. Co. has produced a renewable farnesene brand, Biofene®, a long-chain, branched hydrocarbon molecule that Co. manufactures through fermentation using engineered microbes. Co. has formulated its fermentation-based ingredients such as Squalane, Hemisqualane, and Steviol Glycoside Rebaudioside M into its consumer brands. Co.'s consumer brands include: Biossance® clean beauty skincare, Pipette® clean baby skincare, and Purecane sweetener.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
17,155 |
Total Buy Value |
$0 |
$0 |
$0 |
$69,135 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
0 |
0 |
20,999 |
4,403,696 |
Total Sell Value |
$0 |
$0 |
$19,949 |
$15,923,478 |
Total People Sold |
0 |
0 |
1 |
6 |
Total Sell Transactions |
0 |
0 |
1 |
15 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Weaver Karen |
Principal Accounting Officer |
|
2016-06-01 |
4 |
D |
$0.54 |
$90 |
D/D |
(167) |
75,135 |
|
- |
|
Cherry Joel |
President of R&D |
|
2016-06-01 |
4 |
D |
$0.54 |
$7,441 |
D/D |
(13,779) |
617,873 |
|
- |
|
Khadder Nicholas |
General Counsel and Secretary |
|
2016-06-01 |
4 |
D |
$0.54 |
$6,602 |
D/D |
(12,226) |
402,020 |
|
- |
|
Melo John |
President and CEO |
|
2016-06-01 |
4 |
D |
$0.54 |
$28,749 |
D/D |
(53,238) |
1,308,910 |
|
- |
|
Cherry Joel |
President of R&D |
|
2016-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
631,652 |
|
- |
|
Khadder Nicholas |
General Counsel and Secretary |
|
2016-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
414,246 |
|
- |
|
Melo John |
President and CEO |
|
2016-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
425,000 |
1,362,148 |
|
- |
|
Weaver Karen |
Principal Accounting Officer |
|
2016-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
75,302 |
|
- |
|
Asadorian Raffi |
Chief Financial Officer |
|
2016-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
270,834 |
|
- |
|
Cherry Joel |
President of R&D |
|
2016-04-01 |
4 |
D |
$1.09 |
$27,179 |
D/D |
(24,935) |
431,652 |
|
- |
|
Khadder Nicholas |
General Counsel and Secretary |
|
2016-04-01 |
4 |
D |
$1.09 |
$6,486 |
D/D |
(5,950) |
264,246 |
|
- |
|
Melo John |
President and CEO |
|
2016-04-01 |
4 |
D |
$1.09 |
$73,595 |
D/D |
(67,518) |
937,148 |
|
- |
|
Weaver Karen |
Principal Accounting Officer |
|
2016-04-01 |
4 |
D |
$1.09 |
$1,431 |
D/D |
(1,313) |
37,802 |
|
- |
|
Weaver Karen |
Principal Accounting Officer |
|
2016-03-01 |
4 |
D |
$1.46 |
$291 |
D/D |
(199) |
39,115 |
|
- |
|
Asadorian Raffi |
Chief Financial Officer |
|
2016-01-01 |
4 |
D |
$1.62 |
$47,249 |
D/D |
(29,166) |
170,834 |
|
- |
|
Georgiadis Mary Margaret Hastings |
Director |
|
2015-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
|
- |
|
Georgiadis Mary Margaret Hastings |
Director |
|
2015-12-16 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
20,000 |
|
- |
|
Fullerton Management Pte Ltd |
10% Owner |
|
2015-12-11 |
4 |
OE |
$0.01 |
$127,002 |
D/D |
12,700,244 |
69,592,216 |
|
- |
|
Weaver Karen |
Principal Accounting Officer |
|
2015-12-01 |
4 |
D |
$1.68 |
$287 |
D/D |
(171) |
39,314 |
|
- |
|
Khadder Nicholas |
General Counsel and Secretary |
|
2015-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
54,000 |
270,196 |
|
- |
|
Melo John |
President and CEO |
|
2015-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
1,004,666 |
|
- |
|
Cherry Joel |
President of R&D |
|
2015-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
74,250 |
456,588 |
|
- |
|
Boisseau Philippe |
Director |
|
2015-10-14 |
4 |
S |
$2.36 |
$189,243 |
I/I |
(80,052) |
64,178,185 |
|
- |
|
Boisseau Philippe |
Director |
|
2015-10-14 |
4 |
OE |
$1.42 |
$26,838,289 |
I/I |
18,924,192 |
64,258,237 |
|
- |
|
Total Gas & Power Usa, Sas |
Director by Deputization |
|
2015-10-14 |
4 |
S |
$2.36 |
$189,243 |
D/D |
(80,052) |
64,178,185 |
|
- |
|
402 Records found
|
|
Page 14 of 17 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|